Annexon, Inc. ('Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback